Nora Brennan
Director of Finance/CFO at SPECTRUM PHARMACEUTICALS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Niall M. B. Martin | M | - |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | 8 years |
| Andrew Muncey | M | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | 8 years |
| Megan Smeykal | F | 48 | 5 years | |
| Lisa Colleran | F | 66 | 4 years | |
| Federica O’Brien | F | 66 | 5 years | |
| Raymond Murphy | M | 76 | 15 years | |
| Keith M. McGahan | M | - | 8 years | |
| Marissa Conrad | F | - | 3 years | |
| Barbara Hill | F | 71 | 11 years | |
| Douglas Evans | M | 59 | 4 years | |
| Mathieu Aussermeier | M | - | 7 years | |
| Serena Nik-Zainal | F | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Johann Bono | M | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Jonathan Ledermann | M | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Geoff Shapiro | M | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Bruce Freedman | M | - | 3 years | |
| Peter Murphy | M | 52 | 4 years | |
| Michael McBreen | M | 58 | 7 years | |
| Phil Masterson | M | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Michael A. Grabow | M | - | 11 years | |
| Jonathan Leslie Tobin | M | 42 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Laurene Isip | F | - | 8 years | |
| Michelle Doig | F | 50 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | 3 years |
| Samantha Truex | F | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | 2 years |
| Robert Davis | M | 65 | 12 years | |
| Rajesh Chopra | M | 63 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | 5 years |
| Chen-Ming Yu | M | 50 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Angela Steinway | F | - | 15 years | |
| Hamish Alan Cameron | M | 70 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| René Kuijten | M | 60 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Harry Finch | M | - |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Raphaël Wisniewski | M | 54 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Pierre Legault | M | 63 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | 6 years |
| Michael Carter | M | 86 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Barbara Dalton | M | 69 |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | - |
| Christopher Ward | M | - | 11 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joseph W. Turgeon | M | 66 | 9 years | |
| Thomas Riga | M | 48 | 10 years | |
| Peter Arduini | M | 59 | 11 years | |
| Kurt Gustafson | M | 56 | 9 years | |
| John Henneman | M | 62 | 16 years | |
| Gerard S. Carlozzi | M | 68 | 8 years | |
| Glenn Coleman | M | 56 | 8 years | |
| Barry M. Deutsch | M | 61 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 4 years |
| Beth Hecht | F | 60 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | - |
| Ashley Friedman | M | 46 | 6 years | |
| Jeffrey Vacirca | M | 55 | 5 years | |
| Barbara-Jean Bormann-Kennedy | M | 65 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| William Ashton | M | 73 | 5 years | |
| Neal Moszkowski | M | 58 | 7 years | |
| Lloyd Howell | M | 57 | 8 years | |
| Dolatrai Vyas | M | 80 | 9 years | |
| John Nosenzo | M | 66 | 2 years | |
| Anne VanLent | F | 76 | 16 years | |
| Dawn Halkuff | F | 53 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Brittany Bradrick | F | 54 | 1 years | |
| Donald Morel | M | 67 | 10 years | |
| T. Robert Perrett | M | - | 7 years | |
| John Schmid | M | 61 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 4 years |
| Matthew Zuga | M | 58 | 1 years | |
| Sravan Emany | M | 46 | 3 years | |
| Thomas Baltimore | M | 60 | 5 years | |
| Ju-Hyun Lim | F | 49 | 1 years | |
| Adele Oliva | F | 58 | 9 years | |
| Marla Persky | F | 68 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Elizabeth Czerepak | F | 58 | 1 years | |
| Ronald Ellis | M | 53 | 2 years | |
| Jeffrey Sherman | M | 69 |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | 3 years |
| Maarten Persenaire | M | 67 | 9 years | |
| David Holtz | M | 58 | 13 years | |
| Brian Larkin | M | 55 | 15 years | |
| Shanta P. Chawla | M | 76 | - | |
| Paul Gonsalves | M | - | 7 years | |
| Francois Lebel | M | 72 | 4 years | |
| Kathryn S. Lamping | F | - | 7 years | |
| Brian Baker | M | 57 | - | |
| Jill Quigley | F | 49 | 2 years | |
| Gerrit Dispersyn | M | 49 | 9 years | |
| Joanna Lanni | F | 54 | 1 years | |
| John Mooradian | M | 68 | - | |
| Joseph Vinhais | M | - | 8 years | |
| Gianna Sabella | F | - | - | |
| JoAnne Harla | F | - | - | |
| Ken Yamada | M | - | - | |
| Maureen B. Bellantoni | F | 74 | 1 years | |
| Michael T. Beaulieu | M | - | - | |
| Seth Fischer | M | 68 | 3 years | |
| Jerry E. Corbin | M | 64 | - | |
| Francis M. Conway | M | - | - | |
| John J. Winge | M | 55 | 7 years | |
| Mark Augusti | M | 58 | 2 years | |
| Daniel Reuvers | M | 61 | 12 years | |
| Simon J. Archibald | M | - | 17 years | |
| James A. Oti | M | - | - | |
| Gabrielle Wolfson | F | - | 2 years | |
| Kirtley C. Stephenson | M | 65 | 2 years | |
| Kenneth Burhop | M | 71 | - | |
| Neal Jay Glueck | M | 70 | 8 years | |
| Christopher A. Thatcher | M | 59 | 4 years | |
| Andrea Tommasoli | M | 52 | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 81 | 81.00% |
| United Kingdom | 19 | 19.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nora Brennan
- Personal Network
